The pandemic has proven the need for new technologies that can radically change online learning models. But investors are more interested in existing platforms.
There's been even more good news this week, this time from the Oxford-AstraZeneca trials. But a closer look reveals some very shaky science.
A holiday guide to navigating the deep swamp of polluted information.
Many of the communities most vulnerable to Covid-19 are the ones least willing to get a vaccine. Convincing them may require a peer-to-peer approach.
The company wants to shut down an academic study of political ad targeting, just as it prepares to reinstate targeted political ads.
An ER nurse’s anecdote of deranged denialism went viral. But when the media caught wind of the story, reporters didn’t do their jobs.
YouTube is a major vector for election and other disinformation. But its CEO isn't with Mark Zuckerberg and Jack Dorsey on Capitol Hill today.
It's a good time to salute infrastructure, from the postal system to the CDC. Their often invisible work still needs to be tended—and honored.
Official guidance seems handed down from on high, rather than based on studies. That will make it harder to beat Covid-19.
It seems like a simple way to justify holiday gatherings. But the everyone-has-gotten-tested method is utterly absurd.
Hospitalizations for the disease are at their peak, but the death rate is way down. The simple procedure of flipping people over may be an important reason why.